Open AccessTargeting nanomedicines in the treatment of Crohn’s disease: focus on certolizumab pegol (CDP870)
Author(s) -
César Núñez
Publication year - 2007
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s796
Subject(s) - certolizumab pegol , medicine , crohn's disease , disease , infliximab
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom